Patents by Inventor Mervi Niskanen

Mervi Niskanen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition comprising entracapone, levodopa, and carbidopa
    Patent number: 6797732
    Abstract: An oral solid fixed dose composition comprising pharmacologically effective amounts of entacapone, levodopa, and carbidopa, or pharmaceutically acceptable salts or hydrates thereof, and comprising at least one pharmaceutically acceptable excipient. The composition can be used, e.g., for the treatment of Parkinson's disease.
    Type: Grant
    Filed: August 20, 2002
    Date of Patent: September 28, 2004
    Assignee: Orion Corporation
    Inventors: Matti Virkki, Kari Vahervuo, Marja Ritala, Marja Partanen, Mervi Niskanen, Jarmo Lintulaakso, Marja Laaksonen, Lasse Kervinen, Sari Kallioinen
  • Pharmaceutical composition comprising entracapone, levodopa, and carbidopa
    Publication number: 20030017201
    Abstract: An oral solid fixed dose composition comprising pharmacologically effective amounts of entacapone, levodopa, and carbidopa, or pharmaceutically acceptable salts or hydrates thereof, and comprising at least one pharmaceutically acceptable excipient. The composition can be used, e.g., for the treatment of Parkinson's disease.
    Type: Application
    Filed: August 20, 2002
    Publication date: January 23, 2003
    Inventors: Matti Virkki, Kari Vahervuo, Marja Ritala, Marja Partanen, Mervi Niskanen, Jarmo Lintulaakso, Marja Laaksonen, Lasse Kervinen, Sari Kallioinen
  • Pharmaceutical composition comprising entacapone, levodopa, and carbidopa
    Patent number: 6500867
    Abstract: An oral solid fixed dose composition comprising pharmacologically effective amounts of entacapone, levodopa, and carbidopa, or pharmaceutically acceptable salts or hydrates thereof, and comprising at least one pharmaceutically acceptable excipient. The composition can be used, e.g., for the treatment of Parkinson's disease.
    Type: Grant
    Filed: June 29, 2000
    Date of Patent: December 31, 2002
    Assignee: Orion Corporation
    Inventors: Matti Virkki, Kari Vahervuo, Marja Ritala, Marja Partanen, Mervi Niskanen, Jarmo Lintulaakso, Marja Laaksonen, Lasse Kervinen, Sari Kallioinen